The abstract is read at the publisher; the summary is JClub's.
IGF-1/SLC25A33 maintains blood-labyrinth barrier integrity in aged mouse stria vascularis by suppressing TGF-β/Smad2–mediated pericyte activation.
- Why it matters: Cochlear aging and ARHL involve poorly defined molecular control of pericytes and the blood-labyrinth barrier, limiting mechanistic targets for preserving hearing.
- What they did: Transcriptomics of FACS-purified pericytes from young versus aged mice identified Igf1 and Slc25a33 downregulation with TGF-β pathway enrichment; then pericyte cultures and in vivo AAV/lentiviral modulation tested IGF-1 or SLC25A33 effects using qPCR, western blot, immunostaining, flow cytometry, TEM, and ABR/DPOAE.
- The result: IGF-1 deficiency suppressed SLC25A33, increased mitochondrial ROS, activated TGF-β/Smad2, and shifted pericytes toward α-SMA–high, E-cadherin–low phenotypes; in vivo IGF-1 or SLC25A33 suppression disrupted BLB ultrastructure and worsened hearing, while exogenous IGF-1 or SLC25A33 overexpression attenuated these changes and partially restored auditory function.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.